Search Results - Wanlin Xi

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Cover Image

    Phase I pharmacokinetic study of an oral, small-molecule MEK inhibitor tunlametinib in patients with advanced NRAS mutant melanoma by Qian Zhao, Teng Wang, Huanhuan Wang, Cheng Cui, Wen Zhong, Diyi Fu, Wanlin Xi, Lu Si, Jun Guo, Ying Cheng, Hongqi Tian, Pei Hu

    Published 2022
    Connect to this object online.
    Book

    Save to List
    Saved in:

Search Tools: